Protagonist Therapeutics, Inc.

PTGX

$135.23

Name : Protagonist Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $8,826,476,544.00

EPSttm : 4.73

Protagonist Therapeutics, Inc.

$135.23

0.27%

$0.37

PTGX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

16.59

Margin Of Safety %

-2

Put/Call OI Ratio

0.37

EPS Next Q Diff

-3.08

EPS Last/This Y

7.63

EPS This/Next Y

-5.19

Price

134.76

Target Price

181.73

Analyst Recom

1.07

Performance Q

-10.94

Upside

-54.5%

Beta

1.23

Ticker: PTGX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	PTGX	139.03	0.36	0.42	6912
2026-10-14	PTGX	136.35	0.36	1.07	6919
2026-10-15	PTGX	136.39	0.36	0.06	6918
2026-10-16	PTGX	128.8	0.35	0.59	6959
2026-10-19	PTGX	134.47	0.35	0.00	6379
2026-10-20	PTGX	138.07	0.35	0.00	6386
2026-10-21	PTGX	138.13	0.34	0.00	6444
2026-10-22	PTGX	139.38	0.34	0.00	6469
2026-10-23	PTGX	138.43	0.34	0.00	6512
2026-10-26	PTGX	140.11	0.34	0.00	6553
2026-10-27	PTGX	141.02	0.34	0.42	6551
2026-10-28	PTGX	142.03	0.34	4.67	6566
2026-10-29	PTGX	144.32	0.34	0.50	6575
2026-10-30	PTGX	144.96	0.34	1.82	6577
2026-11-02	PTGX	139.37	0.34	0.25	6601
2026-11-03	PTGX	140.4	0.34	0.50	6602
2026-11-04	PTGX	143.32	0.34	0.60	6615
2026-11-05	PTGX	135.08	0.34	2.06	6622
2026-11-06	PTGX	131.81	0.34	24.50	6639
2026-11-09	PTGX	135.9	0.37	5.00	6742
2026-11-10	PTGX	136.23	0.37	999.99	6747
2026-11-11	PTGX	134.71	0.37	0.04	6750
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	PTGX	138.49	522.6	-	4.76
2026-10-14	PTGX	136.31	522.6	-	4.76
2026-10-15	PTGX	136.50	522.6	-	4.76
2026-10-16	PTGX	128.80	508.3	-	4.66
2026-10-19	PTGX	134.45	508.4	-	4.66
2026-10-20	PTGX	134.45	508.4	-	4.66
2026-10-21	PTGX	138.00	508.4	-	4.66
2026-10-22	PTGX	139.49	508.4	-	4.66
2026-10-23	PTGX	138.40	508.4	-	4.66
2026-10-26	PTGX	140.33	529.2	-	4.77
2026-10-27	PTGX	141.07	529.2	-	4.77
2026-10-28	PTGX	142.05	529.2	-	4.77
2026-10-29	PTGX	144.23	529.2	-	4.77
2026-10-30	PTGX	144.93	529.2	-	4.77
2026-11-02	PTGX	139.37	529.2	-	4.77
2026-11-03	PTGX	140.44	529.2	-	4.77
2026-11-04	PTGX	143.52	529.2	-	4.77
2026-11-05	PTGX	135.20	529.2	-	4.77
2026-11-06	PTGX	132.02	529.2	-	4.77
2026-11-09	PTGX	135.90	26.9	-	4.77
2026-11-10	PTGX	136.18	94.8	-	5.58
2026-11-11	PTGX	134.76	94.8	-	5.58
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	PTGX	-11.35	-4.14	15.27
2026-10-14	PTGX	-11.35	-4.14	15.27
2026-10-15	PTGX	-11.35	-4.14	15.27
2026-10-16	PTGX	-11.35	-4.14	15.27
2026-10-19	PTGX	-11.35	-4.17	15.27
2026-10-20	PTGX	-11.35	-4.17	15.27
2026-10-21	PTGX	-11.35	-4.17	15.27
2026-10-22	PTGX	-11.31	-4.17	15.27
2026-10-23	PTGX	-11.31	-4.17	15.27
2026-10-26	PTGX	-11.31	-4.21	15.27
2026-10-27	PTGX	-11.31	-4.21	16.82
2026-10-28	PTGX	-11.31	-4.21	16.82
2026-10-29	PTGX	-11.31	-4.21	16.82
2026-10-30	PTGX	-11.31	-4.21	16.82
2026-11-02	PTGX	-11.31	-5.75	16.82
2026-11-03	PTGX	-11.31	-5.75	16.82
2026-11-05	PTGX	-11.31	-5.75	16.82
2026-11-06	PTGX	-11.31	-5.75	16.82
2026-11-09	PTGX	-11.31	-6.16	16.82
2026-11-10	PTGX	-11.31	-6.16	16.82
2026-11-11	PTGX	-11.22	-6.16	16.59
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

3.07

Avg. EPS Est. Current Quarter

-0.04

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

-11.22

Institutional Transactions

-6.16

Beta

1.23

Average Sales Estimate Current Quarter

127

Average Sales Estimate Next Quarter

Fair Value

132.65

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

16.2

Max Drawdown 5-Year %

-81

Target Price

181.73

P/E

28.57

Forward P/E

PEG

P/S

15.96

P/B

8.11

P/Free Cash Flow

80.64

EPS

4.72

Average EPS Est. Cur. Y

5.58

EPS Next Y. (Est.)

0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

62.04

Relative Volume

0.51

Return on Equity vs Sector %

5.2

Return on Equity vs Industry %

24.7

EPS 1 7Days Diff

0.8

EPS 1 30Days Diff

0.79

EBIT Estimation

◆ PTGX Healthcare

$134.86

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

19/25

Volume

8/15

Valuation

10/20

TP/AR

5/10

Options

6/10

RSI

43.8

Range 1M

30.1%

Sup Dist

0.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

22/30

Estimates

9/20

Inst/Vol

1/15

Options

10/10

EPS Yr

350.9%

EPS NY

-100.7%

52W%

68.2%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -41.6% upside

Quality

23/30

Valuation

1/30

Growth

17/25

Stability

7/10

LT Trend

1/5

Upside

-41.6%

Quality

MoS

-2%

PTGX — P/E HistoricalBiotechnology

Protagonist Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 149

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

PTGX

Latest News

—

Caricamento notizie per PTGX…

stock quote shares PTGX – Protagonist Therapeutics Inc Stock Price stock today

news today PTGX – Protagonist Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch PTGX – Protagonist Therapeutics Inc yahoo finance google finance

stock history PTGX – Protagonist Therapeutics Inc invest stock market

stock prices PTGX premarket after hours

ticker PTGX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PTGX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y